Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31193446 | 0.97 | PDK2 (0.56) | PDK2PTPN11 | |
| SCHEMBL21464021 | 0.93 | PDK2 (0.52) | PDK2PTPN11 | |
| SCHEMBL15470845 | 0.89 | PDK2 (0.46) | PDK2 | |
| SCHEMBL10251466 | 0.87 | PDK2 (0.54) | PDK2PTPN11 | |
| SCHEMBL15608159 | 0.86 | PDK2 (0.59) | PDK2PTPN11 | |
| SCHEMBL28501701 | 0.81 | PDK2 (0.42) | PDK2PTPN11 | |
| SCHEMBL538516 | 0.80 | PDK2 (0.56) | PDK2PTPN11 | |
| SCHEMBL23094042 | 0.78 | PDK2 (0.50) | PDK2PTPN11 | |
| SCHEMBL539157 | 0.75 | PDK2 (0.50) | PDK2PTPN11 | |
| SCHEMBL31003500 | 0.74 | GPR3 (0.41) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12454526-B2 | Method for producing pyrrole-imidazole (poly)amide | KANEKA CORPORATION (JP) | 2025-10-28 | — | — | US | claimed |
| US-12351601-B2 | Method for producing peptide continuously | AJINOMOTO CO., INC. (JP) | 2025-07-08 | — | — | US | claimed |
| US-20220041648-A1 | METHOD FOR PRODUCING PEPTIDE CONTINUOUSLY | AJINOMOTO CO., INC. (JP) | 2022-02-10 | — | — | US | claimed |
| WO-2020218497-A1 | METHOD FOR PRODUCING PEPTIDE CONTINUOUSLY | 味の素株式会社 | 2020-10-29 | — | — | WO | claimed |
| US-9353147-B2 | Method for producing peptide | AJINOMOTO CO., INC. (JP) | 2016-05-31 | — | — | US | claimed |
| US-9029504-B2 | Fluorene compound | AJINOMOTO CO., INC. (JP) | 2015-05-12 | — | — | US | claimed |
| US-20140088291-A1 | METHOD FOR PRODUCING PEPTIDE | AJINOMOTO CO., INC. (JP) | 2014-03-27 | — | — | US | claimed |
| US-20140046022-A1 | FLUORENE COMPOUND | AJINOMOTO CO., INC. (JP) | 2014-02-13 | — | — | US | claimed |
| EP-2415744-A1 | FLUORENE COMPOUND | Ajinomoto Co., Inc. (JP) | 2012-02-08 | — | — | EP | claimed |
| US-20100240867-A1 | FLUORENE COMPOUND | AJINOMOTO CO. INC. (JP) | 2010-09-23 | — | — | US | claimed |
| US-12351601-B2 | Method for producing peptide continuously | AJINOMOTO CO., INC. (JP) | 2025-07-08 | — | — | US | disclosed |
| US-11939404-B2 | Method for producing cyclized peptide having intramolecular S-S bond | AJINOMOTO CO., INC. (JP) | 2024-03-26 | — | — | US | disclosed |
| EP-4011902-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTING GROUP, AND HYDRAZINE DERIVATIVE | FUJIFILM Corporation (JP) | 2022-06-15 | — | — | EP | disclosed |
| US-20220041648-A1 | METHOD FOR PRODUCING PEPTIDE CONTINUOUSLY | AJINOMOTO CO., INC. (JP) | 2022-02-10 | — | — | US | disclosed |
| EP-3882255-A1 | METHOD FOR PRODUCING CYCLIZED PEPTIDE HAVING INTRAMOLECULAR S-S BOND | AJINOMOTO CO., INC. (JP) | 2021-09-22 | — | — | EP | disclosed |
| US-8569453-B2 | Fluorene compound | AJINOMOTO CO., INC. (JP) | 2013-10-29 | — | — | US | disclosed |
| EP-2415744-A1 | FLUORENE COMPOUND | Ajinomoto Co., Inc. (JP) | 2012-02-08 | — | — | EP | disclosed |
| EP-2415744-A1 | FLUORENE COMPOUND | Ajinomoto Co., Inc. (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20100240867-A1 | FLUORENE COMPOUND | AJINOMOTO CO. INC. (JP) | 2010-09-23 | — | — | US | disclosed |
| WO-2010104169-A1 | FLUORENE COMPOUND | 味の素株式会社 (JP) | 2010-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220041648-A1 | METHOD FOR PRODUCING PEPTIDE CONTINUOUSLY | VIP, NPPA, NGLY1 | PDK2 4375/4885PTPN11 2516/4885 |
| US-20140046022-A1 | FLUORENE COMPOUND | NPPA, FURIN, SFPQ | PDK2 3174/4885PTPN11 4108/4885 |
| US-11939404-B2 | Method for producing cyclized peptide having intramolecular S-S bond | SPPL2B, PTMS, VIP | PDK2 4360/4885PTPN11 3171/4885 |
| US-20100240867-A1 | FLUORENE COMPOUND | NPPA, FURIN, SFPQ | PDK2 3174/4885PTPN11 4108/4885 |
| US-20140088291-A1 | METHOD FOR PRODUCING PEPTIDE | ANPEP, NPPA, LNPEP | PDK2 4613/4885PTPN11 2986/4885 |
| US-12351601-B2 | Method for producing peptide continuously | VIP, NPPA, NGLY1 | PDK2 4375/4885PTPN11 2516/4885 |
| US-12454526-B2 | Method for producing pyrrole-imidazole (poly)amide | DDC, PAM, AADAC | PDK2 502/4885PTPN11 4178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.